Goedert, M. & Spillantini, M. G. Lewy body diseases and multiple system atrophy as α-synucleinopathies. Mol. Psychiatry 3, 462–465 (1998).
Article CAS PubMed Google Scholar
Baba, M. et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879–884 (1998).
CAS PubMed PubMed Central Google Scholar
Wakabayashi, K., Yoshimoto, M., Tsuji, S. & Takahashi, H. α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett. 249, 180–182 (1998).
Article CAS PubMed Google Scholar
Hamilton, R. L. Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry. Brain Pathol. 10, 378–384 (2000).
Article CAS PubMed Google Scholar
Spillantini, M. G. et al. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997).
Article CAS PubMed Google Scholar
Bi, M., Du, X., Jiao, Q., Chen, X. & Jiang, H. Expanding the role of proteasome homeostasis in Parkinson’s disease: beyond protein breakdown. Cell Death Dis. 12, 154 (2021).
Article CAS PubMed PubMed Central Google Scholar
Peng, C., Trojanowski, J. Q. & Lee, V. M. Protein transmission in neurodegenerative disease. Nat. Rev. Neurol. 16, 199–212 (2020).
Article CAS PubMed PubMed Central Google Scholar
Sohrabi, T. et al. Common mechanisms underlying α-synuclein-induced mitochondrial dysfunction in Parkinson’s disease. J. Mol. Biol. 435, 167992 (2023).
Article CAS PubMed Google Scholar
Stykel, M. G. & Ryan, S. D. Nitrosative stress in Parkinson’s disease. NPJ Parkinsons Dis. 8, 104 (2022).
Article PubMed PubMed Central Google Scholar
Maroteaux, L., Campanelli, J. T. & Scheller, R. H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804–2815 (1988).
Article CAS PubMed PubMed Central Google Scholar
Ueda, K. et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 11282–11286 (1993).
Article CAS PubMed PubMed Central Google Scholar
Twohig, D. & Nielsen, H. M. α-Synuclein in the pathophysiology of Alzheimer’s disease. Mol. Neurodegener. 14, 23 (2019).
Article PubMed PubMed Central Google Scholar
Polymeropoulos, M. H. et al. Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045–2047 (1997).
Article CAS PubMed Google Scholar
Appel-Cresswell, S. et al. α-Synuclein p.H50Q, a novel pathogenic mutation for Parkinson’s disease. Mov. Disord. 28, 811–813 (2013).
Article CAS PubMed Google Scholar
Daida, K. et al. α-Synuclein V15A variant in familial Parkinson’s disease exhibits a weaker lipid-binding property. Mov. Disord. 37, 2075–2085 (2022).
Article CAS PubMed PubMed Central Google Scholar
Gadhave, K. et al. α-Synuclein strain dynamics correlate with cognitive shifts in Parkinson’s disease. Preprint at bioRxiv https://doi.org/10.1101/2024.10.22.619694 (2024).
Hoffman-Zacharska, D. et al. Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson’s disease. Parkinsonism Relat. Disord. 19, 1057–1060 (2013).
Article PubMed PubMed Central Google Scholar
Kruger, R. et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nat. Genet. 18, 106–108 (1998).
Article CAS PubMed Google Scholar
Lesage, S. et al. G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann. Neurol. 73, 459–471 (2013).
Article CAS PubMed Google Scholar
Pasanen, P. et al. Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson’s disease-type pathology. Neurobiol. Aging 35, 2180.e1–2180.e5 (2014).
Article CAS PubMed Google Scholar
Yoshino, H. et al. Homozygous α-synuclein p.A53V in familial Parkinson’s disease. Neurobiol. Aging 57, 248.e7–248.e12 (2017).
Article CAS PubMed Google Scholar
Zarranz, J. J. et al. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164–173 (2004).
Article CAS PubMed Google Scholar
Chartier-Harlin, M. C. et al. α-Synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet 364, 1167–1169 (2004).
Article CAS PubMed Google Scholar
Singleton, A. B. et al. α-Synuclein locus triplication causes Parkinson’s disease. Science 302, 841 (2003).
Article CAS PubMed Google Scholar
Lee, V. M. & Trojanowski, J. Q. Mechanisms of Parkinson’s disease linked to pathological α-synuclein: new targets for drug discovery. Neuron 52, 33–38 (2006).
Article CAS PubMed Google Scholar
McNaught, K. S. & Olanow, C. W. Protein aggregation in the pathogenesis of familial and sporadic Parkinson’s disease. Neurobiol. Aging 27, 530–545 (2006).
Article CAS PubMed Google Scholar
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469–6473 (1998).
Article CAS PubMed PubMed Central Google Scholar
Mezey, E. et al. α-Synuclein in neurodegenerative disorders: murderer or accomplice? Nat. Med. 4, 755–757 (1998).
Article CAS PubMed Google Scholar
Galvin, J. E., Giasson, B., Hurtig, H. I., Lee, V. M. & Trojanowski, J. Q. Neurodegeneration with brain iron accumulation, type 1 is characterized by α-, β-, and γ-synuclein neuropathology. Am. J. Pathol. 157, 361–368 (2000).
Article CAS PubMed PubMed Central Google Scholar
Fujiwara, H. et al. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell. Biol. 4, 160–164 (2002).
Article CAS PubMed Google Scholar
Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739–29752 (2006).
Article CAS PubMed Google Scholar
Shahmoradian, S. H. et al. Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099–1109 (2019).
Comments (0)